8-K
filed May 29, 2026, 4:05 PM ET
ticker EXEL
CIK 0000939767
other material
confidence high
sentiment neutral
materiality 0.40
Exelixis shareholders approve 2017 equity plan amendment, adding 2M shares
EXELIXIS, INC.
- Stockholders approved amendment to 2017 Plan, adding 2,000,000 shares to the share reserve.
- Full Value Awards granted on or after May 26, 2026, will count as 1 share per share issued (previously 2 for 1).
- All 11 director nominees elected; Ernst & Young ratified as auditor; say-on-pay approved.
- Amended plan effective immediately upon stockholder approval at May 26, 2026 annual meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
EXELIXIS, INC. shareholders approved Advisory approval of executive compensation (Say on Pay) at the 2026-05-26 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
4. Approval, on an advisory basis, of the compensation of Exelixis’ named executive officers, as disclosed in the Proxy Statement (Say on Pay): Exelixis stockholders approved the Say on Pay proposal. FOR AGAINST ABSTAIN BROKER NON-VOTES 163,104,135 43,156,553 329,618 22,436,080
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
EXELIXIS, INC. shareholders approved Election of 11 directors at the 2026-05-26 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
1. Election of Directors: Exelixis stockholders elected the following 11 directors to serve until the next annual meeting of stockholders in 2027, and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Mary C. Beckerle, Ph.D. 204,854,581 1,538,523 197,202 22,436,080 S. Gail Eckhardt, M.D. 205,409,482 1,022,879 157,945 22,436,080 Maria C. Freire, Ph.D. 180,367,648 26,067,310 155,348 22,436,080 Tomas J. Heyman 200,508,205 5,902,008 180,093 22,436,080 David E. Johnson 205,319,312 1,096,455 174,539 22,436,080 Michael M. Morrissey, Ph.D. 204,731,180 1,692,296 166,830 22,436,080 Robert L. Oliver, Jr. 205,297,039 1,137,865 155,402 22,436,080 Stelios Papadopoulos, Ph.D. 198,500,120 7,922,275 167,911 22,436,080 George Poste, DVM, Ph.D., FRS 204,405,453 2,023,314 161,539 22,436,080 Julie Anne Smith 202,976,810 3,456,942 156,554 22,436,080 Jack L. Wyszomierski 201,891,192 4,536,760 162,354 22,436,080
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
EXELIXIS, INC. shareholders approved Approval of the 2017 Plan at the 2026-05-26 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
3. Approval of the 2017 Plan: Exelixis stockholders approved the 2017 Plan. FOR AGAINST ABSTAIN BROKER NON-VOTES 196,926,657 9,343,837 319,812 22,436,080
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
EXELIXIS, INC. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-26 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
2. Ratification of Ernst & Young LLP as Exelixis’ independent registered public accounting firm: Exelixis stockholders ratified the selection of Ernst & Young LLP as Exelixis’ independent registered public accounting firm for the fiscal year ending January 1, 2027. FOR AGAINST ABSTAIN BROKER NON-VOTES 222,343,120 6,485,691 197,575 —
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.